等待开盘 11-19 09:30:00 美东时间
-0.110
-7.64%
AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(1.57) per share which missed the analyst consensus estimate of $(0.98) by 59.39 percent. This is a 73.83 percent increase over losses of $(6.00) per share from the
11-18 21:57
AIM ImmunoTech Inc. reportedProgress in Cancer Therapy and Positive Financial Developments for Q3 2025
11-18 13:55
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
AIM ImmunoTech Inc. announced positive results from a Phase 2 clinical trial combining Ampligen with cisplatin and pembrolizumab for recurrent platinum-sensitive ovarian cancer. The study achieved a 50% overall response rate, significantly higher than previous pembrolizumab-only trials. Ampligen's ability to enhance immune response could benefit patients resistant to checkpoint inhibitors. The company holds several patents supporting this combina...
11-10 13:55
(来源:Gangtise投研) 一、导言 三巨头均以AI为核心驱动力,但路径分化明显——Meta押注硬件入口,谷歌强化搜索生态,微软重构企...
10-30 09:33
AIM ImmunoTech ( ($AIM) ) has issued an announcement. AIM ImmunoTech has filed ...
10-30 05:51
VSee Health stock jumps after earning FedRAMP High authorization from HHS, paving the way for wider federal use of its AI telehealth platform.
10-29 00:01
在策略蒸馏是一种将强化学习 (RL) 的纠错相关性与 SFT 的奖励密度相结合的训练方法。
10-28 09:56
重要提示:《证券期货投资者适当性管理办法》于2017年7月1日起正式实施,通过本微信订阅号发布的观点和信息仅供国泰海通证券的专业投资者参考,完整的投资观点应以国...
10-28 09:03
波音重型无人机统一平台:技术特征与作战影响分析 摘要:在2025年全球军事技术竞争白热化的背景下,波音公司披露的重型无人机统一平台方案引发国际防务领域高度关注...
10-26 17:43